Achieve Life Sciences (ACHV) Accounts Payables (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Accounts Payables data on file, last reported at $806000.0 in Q1 2026.

• Quarterly Accounts Payables fell 51.33% year-over-year to $806000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $806000.0 (down 51.33% YoY) and the FY2025 annual result came in at $8000.0, down 99.59% from the prior year.
• Accounts Payables advanced to $806000.0 in Q1 2026, from $8000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $2.0 million in Q4 2024 to a low of $8000.0 in Q4 2025.
• A 5-year average of $902411.8 and a median of $656000.0 in 2022 frame the typical range for Accounts Payables.
• The widest YoY moves for Accounts Payables: up 343.97% in 2025, down 99.59% in 2025.
• Tracing ACHV's Accounts Payables over 5 years: stood at $1.7 million in 2022, then slumped by 62.77% to $618000.0 in 2023, then surged by 215.53% to $2.0 million in 2024, then slumped by 99.59% to $8000.0 in 2025, then surged by 9975.0% to $806000.0 in 2026.
• The last three Accounts Payables figures came in at $806000.0 (Q1 2026), $8000.0 (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.